Currax Pharmaceuticals LLC

Huge congrats to our colleagues and partners who were recognized as finalists in the?Fierce Pharma?#FierceMadness 2025 Drug Ad Tournament for our recent TV/streaming advertisement titled "You Don't Own Me." Now is your chance to VOTE ? .?See the ad and cast your vote today, Friday, March 21, by 12 p.m. ET to help us get to the Sweet 16:? https://lnkd.in/ewJM_2y2? #pharma #marketing #healthcare

We are pleased to share that Currax has received FDA approval for a second U.S. manufacturing site. This expansion strengthens our ability to meet the growing demand for effective obesity treatments and reinforces our commitment to uninterrupted patient access. As the need for safe, evidence-based options continues to rise, Currax remains dedicated to investing in manufacturing and advancing research to support both patients and healthcare providers. This milestone ensures continued production capacity while safeguarding against external factors that could impact supply. With global demand for obesity treatments at an all-time high, we are proud to take this step to support patients and healthcare providers. Read the full press release here: https://lnkd.in/eGEJjNTK

In our latest Care Connections video, Robin shares the impact we strive to make: “The product works. It’s going to help people and change their quality of life.” At Currax, our mission is to provide effective solutions that genuinely improve lives. We’re dedicated to empowering patients with the tools they need for a healthier future. Join us on this journey as we continue to innovate and inspire change. #CareConnections #QualityOfLife #CurraxPharma #EmpoweringPatients #HealthcareInnovation

We’re pleased to share that a new peer-reviewed Health Outcomes Analysis (HOA) has been published in?Obesity Pillars, the official journal of the @Obesity Medicine Association, providing valuable real-world insights into long-term obesity treatment and cardiovascular health. This analysis, based on data from 24,600+ patients over 4.7 years, represents a significant contribution to the field, helping to inform clinical decision-making and further substantiate confidence in evidence-based obesity care. A huge thank you to our Currax team, investigators, and collaborators for their dedication to generating high-quality evidence that continues to shape the future of obesity treatment. Read the full press release here:?https://lnkd.in/erBbjdfc ? #ObesityCare #CardiovascularHealth

In our latest Care Connections video, Christian shares what drives us at Currax: “We are focused on the patient and what they need. It’s a part of our vision and mission here at Currax.” Our commitment to being patient-focused guides everything we do. By putting patients first, we strive to create impactful solutions that? make a difference. Stay tuned for more stories and insights as we continue to learn and grow together. #CareConnections #PatientForward #CurraxPharma #EmpoweringPatients #HealthcareInsights

This #WorldObesityDay, let’s shift the focus—it's not about individuals, it's about the systems that need to change. ?? Health, food, media, and government systems all play a role in rising obesity rates. It’s time for action! Together, we can transform these systems and build a healthier future for all.? #ChangingSystems #HealthierLives

Obesity is a chronic disease, not a choice. Everyone deserves access to compassionate, evidence-based care—without stigma. Let's all take the #CommitToCare pledge to advocate for respect and better health for all.

In our latest Care Connections video, Jason shares a powerful perspective: “Let’s bring them into a healing state.” At Currax, we believe healthcare is about more than just treatment—it's about healing, understanding, and supporting patients on their journey to better health. By truly listening and addressing patient needs, we strive to make a meaningful impact every day. Join us as we continue to learn, grow, and work together to bring healing to those who need it most. #CareConnections #HealingJourney #CurraxPharma #EmpoweringPatients #HealthcareInsights

When treating obesity, how you lose weight can be just as important as how much you lose. New findings from a retrospective analysis suggest that patients using an FDA-approved obesity drug experienced weight loss accompanied by favorable changes in body composition. Patients lost significantly more fat mass (12.9% reduction) while better preserving lean muscle mass (only 4.1% reduction) -- a ratio that mirrors the body's natural weight loss process.. ? This is particularly important for patients who need to maintain muscle mass, such as post-menopausal women, as muscle preservation is crucial for metabolic health and physical function. As we continue to advance our understanding of obesity treatment, these findings underscore the importance of providing patients with treatment options that support their specific health needs. Having multiple effective approaches to weight loss means we can better serve the diverse population of patients living with obesity. ? Read more about the research in Diabetes, Obesity and Metabolism here: https://lnkd.in/e-ru4-T4

Currax Pharmaceuticals announced it has reached a mutually satisfactory settlement with Found Health Inc. regarding the proper representation of CONTRAVE? (naltrexone HCl/bupropion HCl). We remain committed to ensuring patients have access to accurate information about their treatment options. To learn more, read the press release here: https://lnkd.in/gxyX6dg4 #curraxpharma #healthcare #pressrelease